Efficacy and Safety of Rifaximin With NAC in IBS-D

Clinical trial NCT04557215 · COMPLETED

Trial details

NCT number: NCT04557215
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea

Start date: 2020-11-13
Primary completion: 2021-08-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.